Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer

Emmanuel S. Antonarakis

doi:10.18632/oncotarget.26296

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer

Emmanuel S. Antonarakis

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	35797-35798
Number of pages	2
Journal	Oncotarget
Volume	9
Issue number	88
DOIs	https://doi.org/10.18632/oncotarget.26296
State	Published - Nov 9 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

AR-V7
eltanexor
prostate cancer
selective inhibitors of nuclear export
selinexor

Publisher link

10.18632/oncotarget.26296

Find It

Find It at U of M Libraries

Cite this

@article{0a2172d55ac847f1a7b47dc697778666,

title = "Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer",

keywords = "AR-V7, eltanexor, prostate cancer, selective inhibitors of nuclear export, selinexor",

author = "Antonarakis, \{Emmanuel S.\}",

year = "2018",

month = nov,

day = "9",

doi = "10.18632/oncotarget.26296",

language = "English (US)",

volume = "9",

pages = "35797--35798",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "88",

}

TY - JOUR

T1 - Selective inhibitors of nuclear export

T2 - potential therapeutics for AR variant-expressing prostate cancer

AU - Antonarakis, Emmanuel S.

PY - 2018/11/9

Y1 - 2018/11/9

KW - AR-V7

KW - eltanexor

KW - prostate cancer

KW - selective inhibitors of nuclear export

KW - selinexor

UR - https://www.scopus.com/pages/publications/85149157063

UR - https://www.scopus.com/pages/publications/85149157063#tab=citedBy

U2 - 10.18632/oncotarget.26296

DO - 10.18632/oncotarget.26296

M3 - Comment/debate

C2 - 30533190

AN - SCOPUS:85149157063

SN - 1949-2553

VL - 9

SP - 35797

EP - 35798

JO - Oncotarget

JF - Oncotarget

IS - 88

ER -

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Cite this